Moneycontrol PRO
HomeNewsBusinessStocksAjanta Pharma shares fall 2.02%; stock among top losers on Nifty Midcap 150

Ajanta Pharma shares fall 2.02%; stock among top losers on Nifty Midcap 150

With the stock's last traded price at Rs 2,480.00, Ajanta Pharma has seen a decline of 2.02% today and is among the top losers on the Nifty Midcap 150.

September 25, 2025 / 14:05 IST
Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Ajanta Pharma shares declined by 2.02% to Rs 2,480.00 in Thursday's session, making it one of the top losers on the Nifty Midcap 150.

    The company's consolidated financial performance shows consistent revenue and profit growth. Revenue for the year-ending March 2025 stood at Rs 4,648.10 Crore, compared to Rs 4,208.71 Crore in the previous year. The net profit for the same period was Rs 920.39 Crore, up from Rs 816.17 Crore in March 2024.

    Here is a summary of Ajanta Pharma's key financial data:

    Financial YearRevenue (Rs Crore)Net Profit (Rs Crore)EPS (Rs)BVPS (Rs)ROE (%)Debt to Equity
    20212,889.69653.8775.09344.5221.820.00
    20223,340.99712.6882.45380.2421.830.00
    20233,742.64587.9845.89268.1417.350.00
    20244,208.71816.1764.82282.3422.870.00
    20254,648.10920.3973.56302.3824.280.00

    The consolidated quarterly results show that the revenue for June 2025 stood at Rs 1,302.65 Crore, compared to Rs 1,144.92 Crore for June 2024. The net profit for the quarter ending June 2025 was Rs 255.34 Crore, up from Rs 245.77 Crore in the same quarter of the previous year.
    QuarterRevenue (Rs Crore)Net Profit (Rs Crore)EPS (Rs)
    Jun 20241,144.92245.7719.54
    Sep 20241,186.64216.4817.27
    Dec 20241,146.13232.8818.60
    Mar 20251,170.41225.2618.00
    Jun 20251,302.65255.3420.44

    Key financial ratios for Ajanta Pharma as of March 2025 include a basic EPS of Rs 73.56, a diluted EPS of Rs 73.53, and a book value per share of Rs 302.38. The company's debt to equity ratio stands at 0.00 as of March 2025.

    The company has announced several corporate actions, including disclosures under SEBI regulations on September 16, 2025, and September 10, 2025. The company announced a bonus issue on May 10, 2022, with a bonus ratio of 1:2 and an ex-bonus date of June 22, 2022. The company also announced a stock split on January 28, 2015, with the old face value of Rs 5 split into a new face value of Rs 2, with an ex-split date of March 20, 2015.

    Recent dividend declarations include an interim dividend of Rs 28 per share (1400%) announced on October 25, 2024, with an effective date of November 6, 2024.

    With the stock's last traded price at Rs 2,480.00, Ajanta Pharma has seen a decline of 2.02% today and is among the top losers on the Nifty Midcap 150.

    Alpha Desk
    first published: Sep 25, 2025 02:05 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347